Pharmaceutical consultation as a tool to improve health outcomes for patients with type 2 diabetes

• Egile Nagusiak: Arnaldo Zubioli (Egilea), Maria Angélica Rafaini Covas Pereira da Silva (Egilea), Raquel Soares Tasca (Egilea), Rui Curi (Egilea), Roberto Barbosa Bazotte (Egilea)
• Formatua: Liburua
• Argitaratua: Universidade de São Paulo, 2013-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

This study develops and evaluates a pharmaceutical consultation program (PCP) to improve treatment for Type 2 diabetes patients (T2DP) and reduce risk factors for diabetic complications with possible application in other chronic diseases. We recruited T2DP receiving conventional medical treatment bu...